Overview

Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of this investigation is to collect information about safety and efficacy of Follistim Injection from actual clinical use to induce ovulation in patients with anovulation and oligoovulation due to hypothalamus-pituitary dysfunction. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Follicle Stimulating Hormone